Sjogren's Syndrome: all 381 studies
Page 4 of 4. Open to participants first (106), then studies with results posted, then the rest; newest registration first within each.
- Implantology and Sjögren's SyndromeCompletedNCT02661243Not applicable
- A Study of LY3090106 in Participants With Sjögren's Syndrome (SS)CompletedNCT02614716Phase 1
- UCB Proof of Concept Study in Patients With Primary Sjögren's SyndromeTerminatedNCT02610543Phase 2
- A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's SyndromeCompletedNCT02503189Phase 3
- An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's SyndromeTerminatedNCT02503176Phase 3
- A Long-term Study of KCT-0809 in Dry Eye Patients With Sjögren's SyndromeCompletedNCT02503163Phase 3
- Study of Pharmacodynamic Effects of VAY736 in Patients With Primary Sjögren's SyndromeWithdrawnNCT02495129Phase 1/2
- A Phase II Study With Low-dose Recombinant Human IL-2 for the Treatment of Primary Sjögren's SyndromeCompletedNCT02464319Phase 2
- Pregnancy and Medically Assisted Conception in Rare DiseasesWithdrawnNCT02450396
- A Longitudinal, Observational Biomarker Study in Participants With Primary Sjogren's SyndromeCompletedNCT02422407
- the Effect of HCG Treatment as a Cardiovascular Disease Morbidity Factor in Sjogren Syndrome PatientsStatus unknownNCT02381587
- Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's SyndromeStatus unknownNCT02370550Phase 4
- Aerobic Exercise in Primary Sjögren's SyndromeCompletedNCT02370225Not applicable
- Evaluation of the Reproducibility Inter-observer of the Ultrasound Anomalies of the Salivary Glands in Sjogren's DiseaseCompletedNCT02358213Not applicable
- Effect of Debridement-scaling on the Relief of Dry Eye Signs and Symptoms in Sjogren's SyndromeCompletedNCT02203188Not applicable
- Treating Dry Eyes and Corneal Ulcers With Fingerprick Autologous BloodStatus unknownNCT02153515Phase 3
- Multi-Colored Placido Disk ViabilityCompletedNCT02148497Not applicable
- Evaluation of Therapeutic Effect of Bandage Contact Lenses ( BCL) on Dry Eye Caused by Sjogren's SyndromeCompletedNCT02147509Not applicable
- Cross-sectional Study of Use of Speckle Method in Early Diagnosis of Cardiovascular DysfunctionStatus unknownNCT02132585
- Examining the Immunological Process of Autoimmune PatientsWithdrawnNCT02123147
- Endoscopic Treatment of Salivary Glands Affected by Sjögren's SyndromeStatus unknownNCT02112019Not applicable
- Evaluation of the Efficacy and the Mechanism of Chinese Herbal Formula SS-1 for Sjögren's SyndromeStatus unknownNCT02110446Phase 2
- Efficacy and Safety of Abatacept in Patients With Primary Sjögren's SyndromeCompletedNCT02067910Phase 3
- A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA StudyCompletedNCT02049112Phase 4
- Effects of Sustained Reading on the Ocular SurfaceTerminatedNCT02031172
- Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II StudyWithdrawnNCT02027298Phase 2
- A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren SyndromeCompletedNCT02011776
- Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye DiseaseCompletedNCT02004067Phase 4
- Primary Sjögren SyndromeCompletedNCT01989819
- Sjogren-Larsson Syndrome: Natural History, Clinical Variation and Evaluation of Biochemical MarkersCompletedNCT01971957
- At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
- Treatment of Dry Eye Using 0.03% Tacrolimus Eye DropsCompletedNCT01850979Phase 4
- Salivary Biomarkers for Sjögren's Syndrome DetectionCompletedNCT01807689
- Rebamipide AND Sjögren SyndromeStatus unknownNCT01759108Not applicable
- Omalizumab for LupusCompletedNCT01716312Phase 1
- Low Dose Cyclosporin A in Primary Sjögren SyndromeCompletedNCT01693393Phase 2
- Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic TreatmentsStatus unknownNCT01642706
- Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's SyndromeCompletedNCT01601028Phase 3
- Exercise in Sjogren, Myositis and Takayasu's ArteritisStatus unknownNCT01501019Not applicable
- A Study of Flt3-Ligand Levels in Sjögrens SyndromeCompletedNCT01470638
- An Evaluation of the Impact of a Single Dose of P-552 on Oral Mucosal WetnessCompletedNCT01369589Phase 1/2
- Pulmozyme for Sjogren's Associated CoughWithdrawnNCT01357447Phase 1
- Cord Blood Serum in the Treatment of Ocular Surface DiseasesCompletedNCT01234623
- Auto-immunity and Pulmonary Arterial HypertensionCompletedNCT01208792Not applicable
- Treatment of Salivary Gland Hypofunction With Neuro- ElectrostimulationStatus unknownNCT01174329Phase 2/3
- Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's SyndromeCompletedNCT01160666Phase 2
- Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic DiseasesStatus unknownNCT01151644Phase 4
- Neurotrophins Implications in Primary Sjögren SyndromeCompletedNCT01081184
- Evaluation of FID 114657 in Sjogren's Syndrome SubjectsCompletedNCT01079871Not applicable
- Efficacy and Safety of Belimumab in Primary Sjögren's SyndromeCompletedNCT01008982Phase 2
- Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome (pSS)Status unknownNCT00953485Phase 1/2
- Confocal Microscopy and Lacrimal Gland in Sjogren's SyndromeStatus unknownNCT00920179
- Effects of Hydroxychloroquine on Oral Complaints of Sjögren PatientsCompletedNCT00873496
- A Safety and Efficacy Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's SyndromeCompletedNCT00852839Phase 2
- Assessment of Inflammatory and Functional Changes in the Ocular Surface Associated With Dry Eye DiseaseCompletedNCT00809003
- Gingival Wetness and Gingival Crevicular Fluid Volume in Patients With Dry MouthCompletedNCT00750828
- Tolerance and Efficacy of Rituximab in Sjogren's DiseaseCompletedNCT00740948Phase 2/3
- Fatigue and Interleukin-1 (IL-1) Blockade in Primary Sjøgrens SyndromeCompletedNCT00683345Phase 2
- Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's SyndromeCompletedNCT00637793Phase 2
- Hydroxychloroquine Versus Placebo in Primary Sjögren's SyndromeCompletedNCT00632866Phase 3
- Evaluation of the Role of the Autonomic Nervous System in Sj(SqrRoot)(Delta)Gren s SyndromeCompletedNCT00565526
- Sex Steroids in Sjögren's Syndrome: Effect of Substitution Treatment on FatigueStatus unknownNCT00543166Phase 4
- Mycophenolate Sodium Treatment in Patients With Primary Sjogren's SyndromeCompletedNCT00542763Phase 1
- Duke Autoimmunity in Pregnancy RegistryCompletedNCT00513591
- Preventive IVIG Therapy for Congenital Heart BlockCompletedNCT00460928Early Phase 1
- A Comparison of Orally Pilocarpine and Artificial Saliva in Xerostomy TreatmentCompletedNCT00438048Phase 4
- Effect of B-cell Depletion in Patients With Primary Sjögren's SyndromeCompletedNCT00426543Phase 2
- Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's SyndromeCompletedNCT00391924Phase 2
- Rituximab Treatment in Sjogren's SyndromeCompletedNCT00363350Phase 1/2
- Anti-CD20 Antibody Therapy for Sjogren's SyndromeCompletedNCT00101829Phase 1
- The Research Registry for Neonatal LupusCompletedNCT00074373
- Study of Oral Bacteria in Patients With Dry MouthCompletedNCT00048685
- Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye SyndromeCompletedNCT00025818Phase 3
- Potential of Transplanted Stem Cells to Mature Into Salivary Gland and Cheek CellsCompletedNCT00023491
- Etanercept Therapy for Sjogren's SyndromeCompletedNCT00001954Phase 2
- The Functioning of Immune and Hormonal Systems in Patients With Sjogren's Syndrome and in Healthy VolunteersCompletedNCT00001953
- Natural History of Salivary Gland Dysfunction and Sjogren's SyndromeCompletedNCT00001852
- Treatment of Dry Eye Syndrome With Cyclosporin A Eye DropsCompletedNCT00001731Phase 2
- Pilot Study of Thalidomide to Treat Sjogren's SyndromeCompletedNCT00001599Phase 2
- DHEA Treatment for Sjogren's SyndromeCompletedNCT00001598Phase 2
- Evaluation of Salivary Gland DysfunctionTerminatedNCT00001196